Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Accent Microcell's Total Stockholders Equity for the quarter that ended in Mar. 2023 was ₹442 Mil. Accent Microcell's Total Assets for the quarter that ended in Mar. 2023 was ₹1,141 Mil.
Therefore, Accent Microcell's Equity to Asset Ratio for the quarter that ended in Mar. 2023 was 0.39.
The historical rank and industry rank for Accent Microcell's Equity-to-Asset or its related term are showing as below:
NSE:ACCENTMIC'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.33 Med: 0.34 Max: 0.39
Current: 0.39
During the past 3 years, the highest Equity to Asset Ratio of Accent Microcell was 0.39. The lowest was 0.33. And the median was 0.34.
NSE:ACCENTMIC's Equity-to-Asset is ranked worse than 72.24% of 1088
companies
in the Drug Manufacturers industry
Industry Median: 0.58
vs NSE:ACCENTMIC: 0.39
Accent Microcell Equity-to-Asset Historical Data
The historical data trend for Accent Microcell's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Accent Microcell Equity-to-Asset Chart
Accent Microcell Annual Data
Trend
Mar21
Mar22
Mar23
Equity-to-Asset
0.33
0.34
0.39
Accent Microcell Semi-Annual Data
Mar21
Mar22
Mar23
Equity-to-Asset
0.33
0.34
0.39
Competitive Comparison of Accent Microcell's Equity-to-Asset
For the Drug Manufacturers - Specialty & Generic subindustry, Accent Microcell's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Accent Microcell's Equity-to-Asset Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Accent Microcell's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Accent Microcell's Equity-to-Asset falls into.
Accent Microcell Equity-to-Asset Calculation
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Accent Microcell's Equity to Asset Ratio for the fiscal year that ended in Mar. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Accent Microcell Equity-to-Asset Related Terms
Thank you for viewing the detailed overview of Accent Microcell's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.
Accent Microcell (NSE:ACCENTMIC) Business Description
Accent Microcell Ltd is a manufacturer of Pharmaceutical Products. It has Products such as Microcrystalline cellulose is a term for refined wood pulp and is used as a texturizer, an anti-caking agent, a fat substitute, an emulsifier, an extender, and a bulking agent in food production; Cross Carmellose Sodium Croscarmellose sodium is an internally cross-linked sodium carboxymethylcellulose for use as a super disintegrant in pharmaceutical formulations; Magnesium Stearate which is also called octadecanoic acid, magnesium salt, is a white substance, powder which becomes solid at room temperature and also produces Cellulose Powder is white or almost white, odourless, tasteless, Practically insoluble in water, dilute acid and organic solvents, Slightly soluble in dilute NaOH solution.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NSE:ACCENTMIC has been successfully added to your